Literature DB >> 28662970

Molecular Dissection of CD8+ T-Cell Dysfunction.

Chao Wang1, Meromit Singer2, Ana C Anderson3.   

Abstract

Chronic viral infections and cancer often lead to the emergence of dysfunctional or 'exhausted' CD8+ T cells, and the restoration of their functions is currently the focus of therapeutic interventions. In this review, we detail recent advances in the annotation of the gene modules and the epigenetic landscape associated with T-cell dysfunction. Together with analysis of single-cell transcriptomes, these findings have enabled a deeper and more precise understanding of the transcriptional mechanisms that induce and maintain the dysfunctional state and highlight the heterogeneity of CD8+ T-cell phenotypes present in chronically inflamed tissue. We discuss the relevance of these findings for understanding the transcriptional and spatial regulation of dysfunctional T cells and for the design of therapeutics.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28662970      PMCID: PMC5759349          DOI: 10.1016/j.it.2017.05.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  62 in total

1.  Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

Authors:  Ben Youngblood; Kenneth J Oestreich; Sang-Jun Ha; Jaikumar Duraiswamy; Rama S Akondy; Erin E West; Zhengyu Wei; Peiyuan Lu; James W Austin; James L Riley; Jeremy M Boss; Rafi Ahmed
Journal:  Immunity       Date:  2011-09-23       Impact factor: 31.745

2.  The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis.

Authors:  Bernhard Mlecnik; Gabriela Bindea; Amos Kirilovsky; Helen K Angell; Anna C Obenauf; Marie Tosolini; Sarah E Church; Pauline Maby; Angela Vasaturo; Mihaela Angelova; Tessa Fredriksen; Stéphanie Mauger; Maximilian Waldner; Anne Berger; Michael R Speicher; Franck Pagès; Viia Valge-Archer; Jérôme Galon
Journal:  Sci Transl Med       Date:  2016-02-24       Impact factor: 17.956

Review 3.  Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.

Authors:  Padmanee Sharma; James P Allison
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

4.  Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults.

Authors:  Jaikumar Duraiswamy; Chris C Ibegbu; David Masopust; Joseph D Miller; Koichi Araki; Gregory H Doho; Pramila Tata; Satish Gupta; Michael J Zilliox; Helder I Nakaya; Bali Pulendran; W Nicholas Haining; Gordon J Freeman; Rafi Ahmed
Journal:  J Immunol       Date:  2011-03-07       Impact factor: 5.422

5.  A vital role for interleukin-21 in the control of a chronic viral infection.

Authors:  John S Yi; Ming Du; Allan J Zajac
Journal:  Science       Date:  2009-05-14       Impact factor: 47.728

6.  Prospects for gene-engineered T cell immunotherapy for solid cancers.

Authors:  Christopher A Klebanoff; Steven A Rosenberg; Nicholas P Restifo
Journal:  Nat Med       Date:  2016-01       Impact factor: 53.440

Review 7.  Combination cancer immunotherapy and new immunomodulatory targets.

Authors:  Kathleen M Mahoney; Paul D Rennert; Gordon J Freeman
Journal:  Nat Rev Drug Discov       Date:  2015-08       Impact factor: 84.694

8.  Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection.

Authors:  Michael A Paley; Daniela C Kroy; Pamela M Odorizzi; Jonathan B Johnnidis; Douglas V Dolfi; Burton E Barnett; Elizabeth K Bikoff; Elizabeth J Robertson; Georg M Lauer; Steven L Reiner; E John Wherry
Journal:  Science       Date:  2012-11-30       Impact factor: 47.728

9.  IRF4 Regulates the Ratio of T-Bet to Eomesodermin in CD8+ T Cells Responding to Persistent LCMV Infection.

Authors:  Ribhu Nayar; Elizabeth Schutten; Sonal Jangalwe; Philip A Durost; Laurie L Kenney; James M Conley; Keith Daniels; Michael A Brehm; Raymond M Welsh; Leslie J Berg
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

10.  IRF4 and BATF are critical for CD8⁺ T-cell function following infection with LCMV.

Authors:  M Grusdat; D R McIlwain; H C Xu; V I Pozdeev; J Knievel; S Q Crome; C Robert-Tissot; R J Dress; A A Pandyra; D E Speiser; E Lang; S K Maney; A R Elford; S R Hamilton; S Scheu; K Pfeffer; J Bode; H-W Mittrücker; M Lohoff; M Huber; D Häussinger; P S Ohashi; T W Mak; K S Lang; P A Lang
Journal:  Cell Death Differ       Date:  2014-02-14       Impact factor: 15.828

View more
  22 in total

1.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

Review 2.  CD8+ T cell states in human cancer: insights from single-cell analysis.

Authors:  Anne M van der Leun; Daniela S Thommen; Ton N Schumacher
Journal:  Nat Rev Cancer       Date:  2020-02-05       Impact factor: 60.716

Review 3.  Bystander T Cells: A Balancing Act of Friends and Foes.

Authors:  Sarah K Whiteside; Jeremy P Snook; Matthew A Williams; Janis J Weis
Journal:  Trends Immunol       Date:  2018-11-06       Impact factor: 16.687

4.  HHLA2 Activates the JAK/STAT Signaling Pathway by Binding to TMIGD2 in Hepatocellular Carcinoma Cells.

Authors:  Hui Guo; Cheng Zhang; Xiaotong Tang; Tiantian Zhang; Yang Liu; Hanbing Yu; Yumei Li; Rui Wang
Journal:  Inflammation       Date:  2022-02-17       Impact factor: 4.092

Review 5.  T cell factor 1: A master regulator of the T cell response in disease.

Authors:  Giulia Escobar; Davide Mangani; Ana C Anderson
Journal:  Sci Immunol       Date:  2020-11-06

6.  Insufficient CD100 shedding contributes to suppression of CD8+ T-cell activity in non-small cell lung cancer.

Authors:  Hong-Min Wang; Xiao-Hong Zhang; Li-Qun Ye; Kai Zhang; Ning-Ning Yang; Shen Geng; Jing Chen; Shun-Xin Zhao; Kang-Li Yang; Fei-Fei Fan
Journal:  Immunology       Date:  2020-04-07       Impact factor: 7.397

7.  The pursuit of transplantation tolerance: new mechanistic insights.

Authors:  Pawan K Gupta; Christine M McIntosh; Anita S Chong; Maria-Luisa Alegre
Journal:  Cell Mol Immunol       Date:  2019-02-13       Impact factor: 11.530

8.  Hypoxia Supports Differentiation of Terminally Exhausted CD8 T Cells.

Authors:  Nadia Bannoud; Tomás Dalotto-Moreno; Lucía Kindgard; Pablo A García; Ada G Blidner; Karina V Mariño; Gabriel A Rabinovich; Diego O Croci
Journal:  Front Immunol       Date:  2021-05-07       Impact factor: 7.561

Review 9.  PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?

Authors:  Sylvain Simon; Nathalie Labarriere
Journal:  Oncoimmunology       Date:  2017-09-14       Impact factor: 8.110

Review 10.  Metabolic and epigenetic regulation of T-cell exhaustion.

Authors:  Fabien Franco; Alison Jaccard; Pedro Romero; Yi-Ru Yu; Ping-Chih Ho
Journal:  Nat Metab       Date:  2020-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.